Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of BK1304 in healthy adults and adolescents
jRCT2080224074Phase 3Completed
- Sponsor
- Research Foundation for Microbial Diseases of Osaka University
- Start
- Oct 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial in influenza comparing BK1304 intranasal vaccine with Intranasal placebo (2 arms). Started Oct 2018; status: completed.
02
Drugs
BK1304
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080224074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224074.